跳至主要内容
临床试验/JPRN-C000000111
JPRN-C000000111已完成3 期

Transarterial infusion chemotherapy using SMANCS with or without embolization in hepatocellular carcinoma: a randomised controlled multicenter phase III trial - Transarterial infusion chemotherapy with or without embolization in hepatocellular carcinoma

Research group for randomised study comparing transcatheter arterial chemoembolization to transarterial infusion chemotherapy0 个研究点目标入组 160 人开始时间: 2005年9月4日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients were excluded if they met the following criteria: extrahepatic metastasis or tumor thrombus in the portal vein and/or the hepatic vein, refractory pleural or peritoneal effusion, a history of allergy to iodine-containing agent and/or contrast material, a history of acute myocardial infarction in preceding 3 months, serious mental disorder, concomitant malignancy, pregnant or lactating women and patients of reproductive potential, intrahepatic arteriovenous shunting, or other serious medical conditions.

研究者

发起方
Research group for randomised study comparing transcatheter arterial chemoembolization to transarterial infusion chemotherapy

相似试验